Approval of the expensive new drug for leukemia, "Kymriah."

The expert meeting of the Ministry of Health, Labour and Welfare seems to have approved the manufacturing and sale of "Kymriah," which Novartis Pharma applied for as a treatment for acute lymphoblastic leukemia using regenerative medicine.
Due to the high medical costs, there is likely to be increased interest in the out-of-pocket expenses in Japan.
Our "Children's Air Coat" helps reduce the formaldehyde present in the air we breathe every day, assisting in measures against the risk of leukemia!
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration
Related Links
Approval of expensive new drug for leukemia